Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms of generalized anxiety disorder (GAD) in clinical trials. However, there is ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies ...

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third ...